May
03
2024
A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.Medscape Medical News (Source: Medscape Diabetes Headlines)
Read More
MedWorm •
Diabetes for Patients •
